January 22, 2019
Posted January 22, 2019
In an investigation lead by Texas and South Carolina, 46 states and the District of Columbia have entered in to a consent judgment with Johnson & Johnson and its DePuy Orthopaedics unit, resolving claims that the company made misleading claims about the lifespan of two of its metal-on-metal hip implant devices, deceptively marketing and unlawfully promoting the medical devices. The company will pay $120 million and agreed to specific steps to reform how it markets and promotes its hip implants. Texas; see also, e.g., NY
Tagged in: Medical Devices and DME,